Bevacizumab Treatment of Radiation-Induced Brain Necrosis: A Systematic Review
BackgroundRadiation brain necrosis (RBN) is a serious complication in patients receiving radiotherapy for intracranial disease. Many studies have investigated the efficacy and safety of bevacizumab in patients with RBN. In the present study, we systematically reviewed the medical literature for stud...
Main Authors: | Guixiang Liao, Muhammad Khan, Zhihong Zhao, Sumbal Arooj, Maosheng Yan, Xianming Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.593449/full |
Similar Items
-
Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis
by: Muhammad Khan, et al.
Published: (2021-02-01) -
Single-shot bevacizumab for cerebral radiation injury
by: Martin Voss, et al.
Published: (2021-02-01) -
Low-Dose Bevacizumab Is Effective in Radiation-Induced Necrosis
by: Matheus Alessandretti, et al.
Published: (2013-12-01) -
Resolution of Radiation-Induced Necrosis in Arteriovenous Malformation with Bevacizumab: A Case Report and Review of Current Literature
by: Forrest Kwong, et al.
Published: (2021-05-01) -
Bevacizumab Combined with Corticosteroids Does Not Improve the Clinical Outcome of Nasopharyngeal Carcinoma Patients With Radiation-Induced Brain Necrosis
by: Honghong Li, et al.
Published: (2021-09-01)